RadNet, one of the largest radiology providers in the United States, has entered into a definitive agreement to acquire DeepHealth, an imaging technology company focused on using AI to improve breast cancer screening.  

Researchers are using advanced technology—including AI, natural language processing (NLP) and satellite imaging—to track how the new coronavirus has impacted China.

Researchers still don’t truly understand how these algorithms work—and that’s a significant issue.

DeepMind, a London-based AI company acquired by Google back in 2014, is sharing predictions made by its advanced AlphaFold system that could help researchers learn more about the new coronavirus.

The newly incorporated American Board of Artificial Intelligence in Medicine (ABAIM) is soon to begin credentialing healthcare workers in AI, machine learning and deep learning.

Owkin, a New York City-based AI startup, announced it is now working with the University of Pittsburgh to design and validate advanced machine learning models. Once finalized, the new models are expected to have a significant impact in areas such as clinical research and the development of pharmaceuticals.

Countless studies have explored AI’s impact on healthcare providers and the patients they serve—but what about the financial side of things? Looking purely at the bottom line, is AI a wise investment?

The Healthcare Information and Management Systems Society (HIMSS) has officially canceled its 2020 annual meeting in Orlando, Florida, due to continued concerns over the new coronavirus.